Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : AGRX    save search

Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: -10.0% H: 21.62% C: 2.1%

year update therapeutics financial results
Agile Therapeutics Announces Delisting from Nasdaq
Published: 2024-03-25 (Crawled : 21:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: -60.23% H: 41.96% C: 39.46%

nasdaq therapeutics
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024Live Conference Call and Webcast at 8:30 a.m. ET
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.0% C: -3.28%

conference report business year update therapeutics financial results
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
Published: 2024-03-21 (Crawled : 11:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.0% C: -3.28%

report business year update therapeutics financial results
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 9.33% C: 9.14%

report business year update therapeutics financial results
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 13.85% H: 0.0% C: -14.94%

business therapeutics
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
Published: 2024-02-22 (Crawled : 14:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 32.03% H: 0.0% C: -27.68%

million therapeutics
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
Published: 2024-02-15 (Crawled : 22:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 2.26% H: 1.6% C: -4.0%

nasdaq granted update extension therapeutics
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
Published: 2024-01-23 (Crawled : 14:30) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 5.41% C: -2.03%

contraceptives
Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement
Published: 2023-12-12 (Crawled : 13:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -6.85%

update care contraceptive therapeutics
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-09 (Crawled : 13:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 1.01% H: 11.56% C: 2.5%

update therapeutics financial results
Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
Published: 2023-10-26 (Crawled : 12:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 1.09% H: 0.0% C: -2.16%

report business update therapeutics financial results
Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-10-04 (Crawled : 20:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 3.97% C: -1.0%

nasdaq grant therapeutics financial
Asia-Pacific Leads the Global Maternal Health Market: Increasing Public Health Awareness and Demand for Innovative Medical Technologies
Published: 2023-09-28 (Crawled : 00:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.25% H: 0.0% C: 0.0%
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 2.29% H: 9.87% C: 7.62%

health global medical
Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-05 (Crawled : 12:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 3.19% H: 0.61% C: -5.02%

conference global therapeutics
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-09 (Crawled : 12:00) - ir.agiletherapeutics.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 2.32% H: 0.38% C: -13.2%

update therapeutics financial results
Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
Published: 2023-07-26 (Crawled : 12:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: -3.11% H: 1.43% C: 0.0%

report business therapeutics financial results
Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
Published: 2023-07-18 (Crawled : 15:00) - biospace.com/
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 6.02% H: 4.1% C: -2.21%

control women therapeutics
H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch
Published: 2023-07-05 (Crawled : 14:00) - biospace.com/
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 3.96% H: 7.94% C: 5.4%

control growing therapeutics
Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
AGRX | $0.37 0.0% 15K twitter stocktwits trandingview |
Health Technology
| | O: 3.91% H: 0.0% C: -6.51%

twirla therapeutics
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.